| How much specific is the association between hymenoptera venom allergy and mastocytosis? P Bonadonna, R Zanotti, M Pagani, B Caruso, O Perbellini, S Colarossi, ... Allergy 64 (9), 1379-1382, 2009 | 105 | 2009 |
| Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and Hymenoptera allergy P Bonadonna, R Zanotti, B Caruso, L Castellani, O Perbellini, S Colarossi, ... Journal of Allergy and Clinical Immunology 121 (1), 256-257, 2008 | 86 | 2008 |
| Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients. G Senna, MB Bilo, L Antonicelli, M Schiappoli, MA Crivellaro, ... European annals of allergy and clinical immunology 36 (6), 215-218, 2004 | 79 | 2004 |
| A prospective Italian survey on the safety of subcutaneous immunotherapy for respiratory allergy M Schiappoli, E Ridolo, G Senna, R Alesina, L Antonicelli, R Asero, ... Clinical & Experimental Allergy 39 (10), 1569-1574, 2009 | 75 | 2009 |
| Evaluation of the IgE cross‐reactions among vespid venoms. A possible approach for the choice of immunotherapy B Caruso, P Bonadonna, MG Severino, M Manfredi, A Dama, ... Allergy 62 (5), 561-564, 2007 | 74 | 2007 |
| Nimesulide and meloxicam are a safe alternative drugs for patients intolerant to nonsteroidal anti-inflammatory drugs. GE Senna, G Passalacqua, A Dama, M Crivellaro, M Schiappoli, ... European annals of allergy and clinical immunology 35 (10), 393-396, 2003 | 66 | 2003 |
| Correlation among FEV1, nitric oxide and asthma control test in newly diagnosed asthma G Senna, G Passalacqua, M Schiappoli, C Lombardi, L Wilcock Allergy 62 (2), 207-208, 2007 | 62 | 2007 |
| Adherence issues related to sublingual immunotherapy as perceived by allergists S Scurati, F Frati, G Passalacqua, P Puccinelli, C Hilaire, C Incorvaia, ... Patient preference and adherence, 141-145, 2010 | 50 | 2010 |
| Fatal asthma; is it still an epidemic? A Vianello, M Caminati, M Crivellaro, R El Mazloum, R Snenghi, ... World Allergy Organization Journal 9, 1-9, 2016 | 41 | 2016 |
| Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience BMC Pulmonary Medicine, 2016 | 40 | 2016 |
| COVID-19 and olfactory dysfunction: an ENT perspective to the current COVID-19 pandemic AV Vroegop, AS Eeckels, V Van Rompaey, D Vanden Abeele, ... B-ENT 16 (1), 81-85, 2020 | 39 | 2020 |
| Complementary and alternative medicine for the treatment and diagnosis of asthma and allergic diseases G Passalacqua, E Compalati, M Schiappoli, G Senna Monaldi archives for chest disease 63 (1), 2005 | 36 | 2005 |
| Dupilumab-induced hypereosinophilia: review of the literature and algorithm proposal for clinical management M Caminati, B Olivieri, A Dama, C Micheletto, P Paggiaro, P Pinter, ... Expert Review of Respiratory Medicine 16 (7), 713-721, 2022 | 33 | 2022 |
| Airborne allergenic pollens in Padua: 1991–1996 M Giorato, F Lorenzoni, A Bordin, G De Biasi, C Gemignani, M Schiappoli, ... Aerobiologia 16, 453-454, 2000 | 33 | 2000 |
| Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety M Caminati, AR Dama, I Djuric, M Montagni, M Schiappoli, E Ridolo, ... Expert Review of Clinical Immunology 11 (2), 233-245, 2015 | 31 | 2015 |
| Asthma under/misdiagnosis in primary care setting: an observational community-based study in Italy MS Magnoni, M Caminati, G Senna, F Arpinelli, A Rizzi, AR Dama, ... Clinical and Molecular Allergy 13, 1-5, 2015 | 30 | 2015 |
| The possible influence of the environment on respiratory allergy: a survey on immigrants to Italy C Lombardi, GW Canonica, G Passalacqua Annals of Allergy, Asthma & Immunology 106 (5), 407-411, 2011 | 28 | 2011 |
| Exercise-induced anaphylaxis to grape G Senna, G Mistrello, D Roncarolo, M Crivellaro, P Bonadonna, ... Allergy 56 (12), 1235-1236, 2001 | 27 | 2001 |
| Omalizumab management beyond clinical trials: the added value of a network model M Caminati, G Senna, FC Bianchi, MR Marchi, A Vianello, C Micheletto, ... Pulmonary Pharmacology & Therapeutics 29 (1), 74-79, 2014 | 23 | 2014 |
| Relevance of TH2 markers in the assessment and therapeutic management of severe allergic asthma: a real-life perspective D Artioli, E Bertocco, L Bonazza, M Crivellaro, F De Conti, A Dama, ... J Investig Allergol Clin Immunol 30 (1), 35-41, 2020 | 22 | 2020 |
Gianenrico SennaAssociate Professor Respiratory Diseases - University of Verona - ItalyEmail verificata su univr.it
